Virtus LifeSci Biotech Products ETF
14 hedge funds and large institutions have $4.83M invested in Virtus LifeSci Biotech Products ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.19M | |
| 2 | -$211K | |
| 3 | -$67.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$44.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$33.6K |